# Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers

> **NCT05194046** · PHASE1 · COMPLETED · sponsor: **Onconic Therapeutics Inc.** · enrollment: 29 (actual)

## Conditions studied

- Helicobacter Pylori Associated Gastrointestinal Disease

## Interventions

- **DRUG:** JP-1366 20mg 1capsule
- **DRUG:** Amoxicillin 500Mg Cap
- **DRUG:** Clarithromycin 500Mg Tab

## Key facts

- **NCT ID:** NCT05194046
- **Lead sponsor:** Onconic Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-18
- **Primary completion:** 2021-01-16
- **Final completion:** 2021-01-19
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2022-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05194046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05194046, "Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05194046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*